The present invention relates to methods and apparatus for treating stuttering via altered auditory feedback. More particularly, the present invention relates to methods and apparatus for treating stuttering by transmitting a user's voice which has been altered via bone conduction through teeth or bone structures in and/or around the mouth.
The causes of stuttering are not fully understood but researchers believe that it may be caused by interference between the left and right hemispheres of the brain competing against one another to send signals to the muscles used to produce speech. These conflicting signals ultimately impair the muscles resulting in stuttering, which is typically characterized by interruptions in speech flow, repetitions, prolongations, and pauses in speech.
The treatments for stuttering are varied and include methods such as psychological therapy, drug, therapy, and altered auditory feedback (AAF). Most AAF treatments can be divided into three categories: delayed auditory feedback (DAF), frequency-shifted auditor, feedback (FAF), and masked auditory feedback (MAF). Treatment using DAF typically utilizes a user's own voice which is delayed between 50 to 200 ms and then relayed back to the user, usually through headphones or an earpiece. This type of treatment relies on the “choral effect”, which occurs when people who stutter speak or sing in unison with others, experience a dramatic reduction or even elimination of stuttering.
Treatments using FAF are based on changing the frequency characteristics of the user's voice by, about a half octave such that the relayed auditory feedback sounds somewhat distorted to the speaker. This frequency shift is believed to effect the user's brain in the same manner as DAF treatment. The MAF treatment involves generating a synthetic sine signal corresponding to the user's own phonetic frequency and relaying this masking feedback to the user.
These treatments usually involve placing a device within the ear canal of the user to completely or partially obstruct the opening much like air-conduction hearing aids. However, such devices are intended to be left in place even when the user is not talking and will also obstruct ambient noises that the user may wish to hear. Moreover, such in-ear devices (as well as other external devices) are usually visible to others and may thus be a deterrent for use by some users for aesthetic reasons. Other devices utilizing such treatments are placed upon a post which is permanently implanted into the skull of the user. However, such devices require invasive surgery and present various complications which may occur as a result.
Accordingly, there exists a need for methods and apparatus for receiving and processing a user's voice and effectively transmitting these processed signals back to the user with minimal obstruction.
An electronic device may be attached, adhered, or otherwise embedded into or upon a removable dental or oral appliance to form an assembly which may conduct audio signals to a user via vibratory conduction through bone. Such a removable oral appliance may be a custom-made device fabricated from a thermal forming process utilizing a replicate model of a dental structure obtained by conventional dental impression methods. The electronic assembly may receive incoming sounds either directly or through a receiver to process and amplify the signals and transmit the processed sounds via a vibrating actuator element coupled to a tooth or other bone structure, such as the maxillary, mandibular, or palatine bone structure.
In using an oral appliance assembly, the oral appliance may utilize altered auditory feedback (AAF) for the treatment of stuttering. Accordingly, in one example of treating stuttering via delayed auditory feedback (DAF) and/or frequency-shifted auditory feedback (FAF), the user's own voice may be received via a microphone located upon the oral assembly or separately from the oral appliance. The user's voice may then be processed such that the voice data is delayed by about, e.g., 60 ms. The delay in the auditory feedback may alternatively range anywhere from about 50 ms to 200 ms.
In addition to delaying the auditory feedback, the auditory feedback signal may also be shifted in frequency by about, e.g., +500 Hz. In other variations, the frequency may be shifted anywhere from less than a half octave to a full octave or more, depending upon the desired results. With the auditor, feedback delayed and shifted in frequency, the signal may be further adjusted or equalized to account for the user's particular bone conduction profile, which may be obtained utilizing standard bone conduction measurements. Accounting for the user's bone conduction profile, particularly through the skull, may facilitate optimization of the altered auditory feedback signal by adjusting particular frequencies or adjusting amplitude or gain such that the vibrationally conducted altered feedback signal reaches the user's middle and/or inner ear with minimal loss.
Once the altered feedback signal has been appropriately adjusted for delay, frequency, bone conduction, etc., it may be vibrationally transmitted via the removable oral appliance through the user's tooth or teeth or other bone structure such as the palatal or mandibular bone, etc. Thus, as the user speaks their voice is sampled and adjusted, as described above, and then retransmitted via the removable oral appliance to effect AAF treatment and to reduce or eliminate stuttering.
The assembly for transmitting vibrations via at least one tooth may generally comprise a housing having a shape which is conformable to at least a portion of the at least one tooth, and an actuator disposed within or upon the housing and in vibratory communication with a surface of the at least one tooth. Moreover, the actuator itself may be a separate assembly from the electronics and may be positioned along another surface of the tooth, such as the occlusal surface, or even attached to an implanted post or screw embedded into the underlying bone.
The actuator utilized in the actuator assembly may be an electromagnetic or piezoelectric actuator. Piezoelectric transducers in particular may be used in various configurations due in part to the various vibrational modes which may be utilized to transmit the acoustic signals as vibrations through a tooth or teeth. Any number of actuator may be utilized for particular applications. For instance, low voltage multi-layer piezoelectric actuator manufactured by Morgan Electro Ceramics Ltd. (Wrexham, England) may be utilized for the applications described herein.
Aside from actuator and housing assemblies which are positioned along or against one or more teeth, actuator assemblies may be alternatively mounted along a retainer-like structure configured for placement adjacent or along the palate of the user. An arch may extend between coupling portions which are configured to extend from the arch for placement against the lingual surfaces of teeth on opposite sides of the user's dentition. Rather than utilizing actuator assemblies directly upon the teeth, the actuator may be removably or permanently integrated along the arch such that elongational vibration of the actuator conducts the vibrations along the arch for transmission through the coupling portions and into the user's teeth. Alternatively, one or more actuators may be positioned along the arch and actuated to directly conduct vibrations through the user's palatal bone.
In treating stuttering, methods and apparatus may utilize altered auditory feedback (AAF) treatments. For instance, the most commonly used treatments may include use of delayed auditory feedback (DAF) and/or frequency-shifted auditor) feedback (FAF). A user's own voice may be modified by delaying the retransmission of the voice back to the user and the voice may also be modified in frequency prior to its retransmission. Rather than utilizing an in-ear device, which obstructs the ear canal, or a device which is coupled to a post implanted in the user, the user's voice may be processed and transmitted via bone conduction through an unobstructive and removable oral appliance.
The removable oral appliance may contain an electronic and actuator device attached, adhered, or otherwise embedded into or upon the oral appliance or other oral device to form an assembly which may conduct audio signals to the user via vibratory, conduction through bone. Such an oral appliance may be a custom-made device fabricated from a thermal forming, process utilizing a replicate model of a dental structure obtained by conventional dental impression methods. The electronic and actuator assembly may receive incoming sounds, such as the user's own voice, either directly or through a receiver to process and amplify the signals and transmit the processed sounds via a vibrating actuator element coupled to a tooth or other bone structure, such as the maxillary, mandibular, or palatine bone structure.
Detailed examples and descriptions of the oral appliance and methods of use are more full), described in the following U.S. patent application Ser. Nos. 11/672,239 filed Feb. 7, 2007; 11/741,648 filed Apr. 27, 2007; and 11/754,823 and 11/754,833 both filed May 29, 2007. Each of these applications is incorporated herein by reference in its entirety.
As shown in
Generally, the volume of electronics and/or actuator assembly 16 may be minimized so as to be unobtrusive and comfortable to the user when placed in the mouth. Although the size may be varied, a volume of assembly 16 may be less than 800 cubic millimeters. This volume is, of course, illustrative and not limiting as size and volume of assembly 16 and may be varied accordingly between different users.
Moreover, removable oral appliance 18 may be fabricated from various polymeric or a combination of polymeric and metallic materials using any number of methods, such as computer-aided machining processes using computer numerical control (CNC) systems or three-dimensional printing processes, e.g. stereolithography apparatus (SLA), selective laser sintering (SLS), and/or other similar processes utilizing three-dimensional geometry of the patient's dentition, which may be obtained via any number of techniques. Such techniques may include use of scanned dentition using intra-oral scanners such as laser, white light, ultrasound, mechanical three-dimensional touch scanners, magnetic resonance imaging (MRI), computed tomography (CT), other optical methods, etc. Examples for manufacturing the oral appliance are described in further detail in U.S. patent application Ser. No. 11/841,477 filed Aug. 20, 2007, which is incorporated herein by reference in its entirety.
In forming the removable oral appliance 18, the appliance 18 may be optionally formed such that it is molded to fit over the dentition and at least a portion of the adjacent gingival tissue to inhibit the entry of food, fluids, and other debris into the oral appliance 18 and between the actuator assembly and tooth surface. Moreover, the greater surface area of the oral appliance 18 may facilitate the placement and configuration of the assembly 16 onto the appliance 18.
Additionally, the removable oral appliance 18 may be optionally fabricated to have a shrinkage factor such that when placed onto the dentition, oral appliance 18 may be configured to securely grab onto the tooth or teeth is the appliance, 18 may have a resulting size slightly smaller than the scanned tooth or teeth upon which the appliance 18 was formed. The fitting, may result in a secure interference fit between the appliance 18 and underlying dentition.
In one variation, with assembly 14 positioned upon the teeth, as shown in
The transmitter assembly 22, as described in further detail below, may contain a microphone assembly as well as a transmitter assembly and may be configured in any number of shapes and forms worn by the user, such as a watch, necklace, lapel, phone, belt-mounted device, etc.
With respect to microphone 30, a variety of various microphone systems may be utilized. For instance, microphone 30 mat be a digital, analog, and/or directional type microphone. Such various types of microphones may be interchangeably configured to be utilized with the assembly, if so desired. Moreover, various configurations and methods for utilizing multiple microphones within the user's mouth may also be utilized, as further described below.
Power supply 36 may be connected to each of the components in transmitter assembly 22 to provide power thereto. The transmitter signals 24 may be in any wireless form utilizing, e.g. radio frequency, ultrasound, microwave. Blue Tooth® (BLUETOOTH SIG, INC., Bellevue, Wash.), etc. for transmission to assembly 16. Assembly 22 may also optionally include one or more input controls 28 that a user may manipulate to adjust various acoustic parameters of the electronics and/or actuator assembly 16, such as acoustic focusing, volume control, filtration, muting, frequency optimization, sound adjustments, and tone adjustments, etc.
The signals transmitted 24 by transmitter 34 may be received by electronics and/or actuator assembly 16 via receiver 38, which may be connected to an internal processor for additional processing of the received signals. The received signals may be communicated to actuator 40, which may vibrate correspondingly against a surface of the tooth to conduct the vibratory signals through the tooth and bone and subsequently to, the middle ear to facilitate hearing of the user. Actuator 40 may be configured as any number of different vibratory mechanisms. For instance, in one variation, actuator 40 may be an electromagnetically actuated actuator. In other variations, actuator 40 may be in the form of a piezoelectric crystal having a range of vibratory frequencies, e.g., between 250 to 15,000 Hz.
Power supply 42 may also be included with assembly 16 to provide power to the receiver, actuator, and/or processor, if also included. Although power supply 42 may be a simple battery, replaceable or permanent, other variations may include a power supply 42 which is charged by inductance via an external charger. Additionally, power supply 42 may alternatively be charged via direct coupling to an alternating current (AC) or direct current (DC) source. Other variations may include a power supply 42 which is charged via a mechanical mechanism such as an internal pendulum or slidable electrical inductance charger as known in the art, which is actuated via. e.g., motions of the jaw and/or movement for translating the mechanical motion into stored electrical energy for charging power supply 42.
In another variation of assembly 16, rather than utilizing an extra-buccal transmitter, hearing aid assembly 50 may be configured as an independent assembly contained entirely within the user's mouth, as shown in
In order to transmit the vibrations corresponding to the received auditory signals efficiently and with minimal loss to the tooth or teeth, secures mechanical contact between the actuator and the tooth is ideally maintained to ensure efficient vibratory communication. Accordingly, any number of mechanisms may be utilized to maintain this vibratory communication.
For any of the variations described above, they may be utilized as a single device or in combination with any other variation herein as practicable, to achieve the desired hearing level in the user. Moreover, more than one oral appliance device and electronics and/or actuator assemblies may be utilized at any one time. For example,
Moreover, each of the different actuators 60, 62, 64, 66 can also be programmed to vibrate in a manner which indicates the directionality of sound received by the microphone worn by the user. For example, different actuators positioned at different locations within the user's mouth can vibrate in a specified manner by providing sound or vibrational queues to inform the user which direction a sound was detected relative to an orientation of the user, as described in further detail below. For instance, a first actuator located. e.g., on a user's left tooth, can be programmed to vibrate for sound detected originating from the user's left side. Similarly, a second actuator located. e.g., on a user's right tooth, can be programmed to vibrate for sound detected originating from the user's right side. Other variations and queues may be utilized as these examples are intended to be illustrative of potential variations.
In yet another variation for separating the microphone from the actuator assembly,
In utilizing multiple actuators and/or processing units, several features may be incorporated with the oral appliance(s) to effect any number of enhancements to the quality of the conducted vibrators signals and/or to emulate various perceptual features to the user to correlate auditory signals received by a user for transmitting these signals via bone conduction through teeth or bone structures in and/or around the mouth. Examples of various processing methods and systems for simulating directionality as well as for processing algorithms for filtering out undesirable signals, among other features, are shown and described in further detail in U.S. patent application Ser. No. 11/672,239 filed Feb. 7, 2007, which is incorporated herein by reference in its entirety. The features shown and described mats be utilized with any of the variations described herein and in any number of combinations as practicable.
In using any of the variations of the oral appliance assembly described herein, the oral appliance may utilize AAF for the treatment of stuttering, as illustrated in one example in the flow chart of
In addition to delaying the auditory feedback, the auditory feedback signal may also be shifted in frequency 114 by about, e.g., +500 Hz. In other variations, the frequency may be shifted anywhere from less than a half octave to a full octave or more, depending upon the desired results. With the auditory feedback delayed and shifted in frequency, the signal may be further adjusted or equalized to account for the user's particular bone conduction profile 116, which may be obtained utilizing standard bone conduction measurements. Accounting for the user's bone conduction profile, particularly through the skull, may facilitate optimization of the altered auditory feedback signal by adjusting particular frequencies or adjusting amplitude or gain such that the vibrationally conducted altered feedback signal reaches the user's middle and/or inner ear with minimal loss.
Once the altered feedback signal has been appropriately adjusted for delay, frequency, bone conduction, etc., it may be vibrationally transmitted via the removable oral appliance 118 through the user's tooth or teeth or other bone structure such as the palatal or mandibular bone, etc. Thus, as the user speaks their voice is sampled and adjusted, as described above, and then retransmitted via the removable oral appliance to effect AAF treatment and to reduce or eliminate stuttering.
In other variations, rather than utilizing both DAF and FAF in altering the auditory feedback signal, DAF treatment may be utilized alone, as illustrated in the flowchart of
In determining the amount of delay to adjust the auditory feedback signal, it may be delayed anywhere from about 50 ms to 200 ms, as mentioned above. As shown in chart 120 in
The applications of the devices and methods discussed above are not limited to the treatment of hearing loss but may include any number of further treatment applications. Moreover, such devices and methods may be applied to other treatment sites within the body. Modification of the above-described assemblies and methods for carrying out the invention, combinations between different variations as practicable, and variations of aspects of the invention that are obvious to those of skill in the art are intended to be within the scope of the claims.
Number | Name | Date | Kind |
---|---|---|---|
2045404 | Nicholides | Jun 1936 | A |
2161169 | Jefferis | Jun 1939 | A |
2318872 | Madiera | May 1943 | A |
2977425 | Cole | Mar 1961 | A |
2995633 | Puharich et al. | Aug 1961 | A |
3156787 | Puharich et al. | Nov 1964 | A |
3170993 | Puharich et al. | Feb 1965 | A |
3267931 | Puharich et al. | Aug 1966 | A |
3325743 | Blum | Jun 1967 | A |
3787641 | Santori | Jan 1974 | A |
3894196 | Briskey | Jul 1975 | A |
3985977 | Beaty et al. | Oct 1976 | A |
4025732 | Traunmuller | May 1977 | A |
4150262 | Ono | Apr 1979 | A |
4498461 | Hakansson | Feb 1985 | A |
4591668 | Iwata | May 1986 | A |
4612915 | Hough et al. | Sep 1986 | A |
4642769 | Petrofsky | Feb 1987 | A |
4738268 | Kipnis | Apr 1988 | A |
4817044 | Ogren | Mar 1989 | A |
4832033 | Maher et al. | May 1989 | A |
4920984 | Furumichi et al. | May 1990 | A |
4982434 | Lenhardt et al. | Jan 1991 | A |
5012520 | Steeger | Apr 1991 | A |
5033999 | Mersky | Jul 1991 | A |
5047994 | Lenhardt et al. | Sep 1991 | A |
5060526 | Barth et al. | Oct 1991 | A |
5082007 | Adell | Jan 1992 | A |
5233987 | Fabian et al. | Aug 1993 | A |
5323468 | Bottesch | Jun 1994 | A |
5325436 | Soli et al. | Jun 1994 | A |
5372142 | Madsen et al. | Dec 1994 | A |
5402496 | Soli et al. | Mar 1995 | A |
5403262 | Gooch | Apr 1995 | A |
5447489 | Issalene et al. | Sep 1995 | A |
5455842 | Merskey et al. | Oct 1995 | A |
5460593 | Mersky et al. | Oct 1995 | A |
5546459 | Sih et al. | Aug 1996 | A |
5558618 | Maniglia | Sep 1996 | A |
5565759 | Dunstan | Oct 1996 | A |
5616027 | Jacobs et al. | Apr 1997 | A |
5624376 | Ball et al. | Apr 1997 | A |
5661813 | Shimauchi et al. | Aug 1997 | A |
5706251 | May | Jan 1998 | A |
5760692 | Block | Jun 1998 | A |
5800336 | Ball et al. | Sep 1998 | A |
5812496 | Peck | Sep 1998 | A |
5828765 | Gable | Oct 1998 | A |
5902167 | Filo et al. | May 1999 | A |
5914701 | Gersheneld et al. | Jun 1999 | A |
5961443 | Rastatter et al. | Oct 1999 | A |
5984681 | Huang | Nov 1999 | A |
6029558 | Stevens et al. | Feb 2000 | A |
6047074 | Zoels et al. | Apr 2000 | A |
6068590 | Brisken | May 2000 | A |
6072884 | Kates | Jun 2000 | A |
6072885 | Stockham, Jr. et al. | Jun 2000 | A |
6075557 | Holliman et al. | Jun 2000 | A |
6115477 | Filo et al. | Sep 2000 | A |
6118882 | Haynes | Sep 2000 | A |
6171229 | Kroll et al. | Jan 2001 | B1 |
6223018 | Fukumoto et al. | Apr 2001 | B1 |
6239705 | Glen | May 2001 | B1 |
6333269 | Naito et al. | Dec 2001 | B2 |
6377693 | Lippa et al. | Apr 2002 | B1 |
6394969 | Lenhardt | May 2002 | B1 |
6504942 | Hong et al. | Jan 2003 | B1 |
6538558 | Sakazume et al. | Mar 2003 | B2 |
6585637 | Brillhart et al. | Jul 2003 | B2 |
6631197 | Taenzer | Oct 2003 | B1 |
6633747 | Reiss | Oct 2003 | B1 |
6682472 | Davis | Jan 2004 | B1 |
6754472 | Williams et al. | Jun 2004 | B1 |
6778674 | Panasik et al. | Aug 2004 | B1 |
6826284 | Benesty et al. | Nov 2004 | B1 |
6885753 | Bank | Apr 2005 | B2 |
6917688 | Yu et al. | Jul 2005 | B2 |
6941952 | Rush, III | Sep 2005 | B1 |
6954668 | Cuozzo | Oct 2005 | B1 |
6985599 | Asnes | Jan 2006 | B2 |
7003099 | Zhang et al. | Feb 2006 | B1 |
7033313 | Lupin et al. | Apr 2006 | B2 |
7035415 | Belt et al. | Apr 2006 | B2 |
7074222 | Westerkull | Jul 2006 | B2 |
7076077 | Atsumi et al. | Jul 2006 | B2 |
7099822 | Zangi | Aug 2006 | B2 |
7162420 | Zangi et al. | Jan 2007 | B2 |
7171003 | Venkatesh et al. | Jan 2007 | B1 |
7171008 | Elko | Jan 2007 | B2 |
7174022 | Zhang et al. | Feb 2007 | B1 |
7206423 | Feng et al. | Apr 2007 | B1 |
7246058 | Burnett | Jul 2007 | B2 |
7258533 | Tanner et al. | Aug 2007 | B2 |
7269266 | Anjanappa et al. | Sep 2007 | B2 |
7271569 | Oglesbee | Sep 2007 | B2 |
7310427 | Retchin et al. | Dec 2007 | B2 |
7329226 | Ni et al. | Feb 2008 | B1 |
7331349 | Brady et al. | Feb 2008 | B2 |
7333624 | Husung | Feb 2008 | B2 |
7361216 | Kangas et al. | Apr 2008 | B2 |
7409070 | Pitulia | Aug 2008 | B2 |
7486798 | Anjanappa et al. | Feb 2009 | B2 |
7520851 | Davis et al. | Apr 2009 | B2 |
7522738 | Miller, III | Apr 2009 | B2 |
7522740 | Julstrom et al. | Apr 2009 | B2 |
20010003788 | Ball et al. | Jun 2001 | A1 |
20010051776 | Lenhardt | Dec 2001 | A1 |
20020026091 | Leysieffer | Feb 2002 | A1 |
20020071581 | Leysieffer et al. | Jun 2002 | A1 |
20020077831 | Numa | Jun 2002 | A1 |
20020122563 | Schumaier | Sep 2002 | A1 |
20020173697 | Lenhardt | Nov 2002 | A1 |
20030059078 | Downs et al. | Mar 2003 | A1 |
20030091200 | Pompei | May 2003 | A1 |
20030212319 | Magill | Nov 2003 | A1 |
20040057591 | Beck et al. | Mar 2004 | A1 |
20040131200 | Davis | Jul 2004 | A1 |
20040141624 | Davis et al. | Jul 2004 | A1 |
20040202339 | O'Brien, Jr. et al. | Oct 2004 | A1 |
20040202344 | Anjanappa et al. | Oct 2004 | A1 |
20040243481 | Bradbury et al. | Dec 2004 | A1 |
20040247143 | Lantrua et al. | Dec 2004 | A1 |
20050037312 | Uchida | Feb 2005 | A1 |
20050067816 | Buckman | Mar 2005 | A1 |
20050070782 | Brodkin | Mar 2005 | A1 |
20050129257 | Tamura | Jun 2005 | A1 |
20050196008 | Anjanappa et al. | Sep 2005 | A1 |
20050241646 | Sotos et al. | Nov 2005 | A1 |
20060008106 | Harper | Jan 2006 | A1 |
20060025648 | Lupin et al. | Feb 2006 | A1 |
20060064037 | Shalon et al. | Mar 2006 | A1 |
20060167335 | Park et al. | Jul 2006 | A1 |
20060270467 | Song et al. | Nov 2006 | A1 |
20060275739 | Ray | Dec 2006 | A1 |
20070010704 | Pitulia | Jan 2007 | A1 |
20070036370 | Granovetter et al. | Feb 2007 | A1 |
20070041595 | Carazo et al. | Feb 2007 | A1 |
20070142072 | Lassally | Jun 2007 | A1 |
20070230713 | Davis | Oct 2007 | A1 |
20070242835 | Davis | Oct 2007 | A1 |
20070265533 | Tran | Nov 2007 | A1 |
20070276270 | Tran | Nov 2007 | A1 |
20070280491 | Abolfathi | Dec 2007 | A1 |
20070280492 | Abolfathi | Dec 2007 | A1 |
20070280493 | Abolfathi | Dec 2007 | A1 |
20070280495 | Abolfathi | Dec 2007 | A1 |
20070286440 | Abolfathi et al. | Dec 2007 | A1 |
20070291972 | Abolfathi et al. | Dec 2007 | A1 |
20080019542 | Menzel et al. | Jan 2008 | A1 |
20080019557 | Bevirt et al. | Jan 2008 | A1 |
20080021327 | El-Bialy et al. | Jan 2008 | A1 |
20080064993 | Abolfathi et al. | Mar 2008 | A1 |
20080070181 | Abolfathi et al. | Mar 2008 | A1 |
20080304677 | Abolfathi et al. | Dec 2008 | A1 |
20090022351 | Wieland et al. | Jan 2009 | A1 |
20090028352 | Petroff | Jan 2009 | A1 |
20090052698 | Rader et al. | Feb 2009 | A1 |
20090088598 | Abolfathi | Apr 2009 | A1 |
20090097684 | Abolfathi et al. | Apr 2009 | A1 |
20090097685 | Menzel et al. | Apr 2009 | A1 |
20090099408 | Abolfathi et al. | Apr 2009 | A1 |
20090105523 | Kassayan et al. | Apr 2009 | A1 |
20090147976 | Abolfathi | Jun 2009 | A1 |
20090149722 | Abolfathi et al. | Jun 2009 | A1 |
20090180652 | Davis et al. | Jul 2009 | A1 |
Number | Date | Country |
---|---|---|
0715838 | Jun 1996 | EP |
0741940 | Nov 1996 | EP |
0824889 | Feb 1998 | EP |
1299052 | Feb 2002 | EP |
1633284 | Dec 2004 | EP |
1691686 | Aug 2006 | EP |
1718255 | Nov 2006 | EP |
1783919 | May 2007 | EP |
2007028248 | Feb 2007 | JP |
2007028610 | Feb 2007 | JP |
2007044284 | Feb 2007 | JP |
2007049599 | Feb 2007 | JP |
2007049658 | Feb 2007 | JP |
WO 8302047 | Jun 1983 | WO |
WO 9102678 | Mar 1991 | WO |
WO 9519678 | Jul 1995 | WO |
WO 9621335 | Jul 1996 | WO |
WO 0209622 | Feb 2002 | WO |
WO 2004045242 | May 2004 | WO |
WO 2004105650 | Dec 2004 | WO |
WO 2005000391 | Jan 2005 | WO |
WO 2005037153 | Apr 2005 | WO |
WO 2005053533 | Jun 2005 | WO |
WO 2006088410 | Aug 2006 | WO |
WO 2006130909 | Dec 2006 | WO |
WO 2007043055 | Apr 2007 | WO |
WO 2007052251 | May 2007 | WO |
WO 2007059185 | May 2007 | WO |
WO 2007140367 | Dec 2007 | WO |
WO 2007140368 | Dec 2007 | WO |
WO 2007140373 | Dec 2007 | WO |
WO 2007143453 | Dec 2007 | WO |
WO 2008024794 | Feb 2008 | WO |
WO 2008030725 | Mar 2008 | WO |
WO 2009014812 | Jan 2009 | WO |
WO 2009025917 | Feb 2009 | WO |
WO 2009066296 | May 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20090210231 A1 | Aug 2009 | US |